ChemOvation

ChemOvation is a private, London-based consultancy firm offering specialized drug discovery and development services, primarily in medicinal chemistry and peptide synthesis. Founded and led by Dr. Ian Matthews, a veteran with over 35 years of industry experience, the company leverages deep technical expertise to support client programs from early discovery towards preclinical development. Its business model is service-based, generating revenue through project-specific collaborations with biopharma companies and academic institutions.

Expertise-led platform in medicinal chemistry, process R&D, peptide synthesis (solid/solution phase), biochemical/biophysical screening, and peptide/protein/antibody labeling.

Competes with large, full-service Contract Research Organizations (CROs) and other small-molecule/peptide-focused consultancies. Differentiation is based on deep, personalized experience of its principal rather than scale or broad service catalogs.